Home > Insider Trading > Glaukos Corp

Glaukos Corp (GKOS)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
31 - 37

Cupps Capital Slashes Portfolio in Q3, But Couldn't Stop Buying These 5 Stocks

Drew Cupps' Chicago-based asset management firm, Cupps Capital Management, has been in the news of late after it announced that its five-member investment team will be joining Advisory Research, Inc., ...

Keep Reading →

November 15th, 2016 - Hedge Fund Analysis Hedge Funds News

Here’s Why Eleven Bio, SouFun, Glaukos, Match Group, and Triumph Group Are Surging Today

U.S. stocks continue to tumble on Wednesday, driven by weak economic data out of the U.S, disappointing corporate financial results, and declining metal prices.

Keep Reading →

May 4th, 2016 - Market Movers News

What You Need to Know About These 4 Stocks Deep in the Red Today

Volatility isn't going away on the 13th day of the year, as all three indexes are now in the red after opening up substantially higher in the morning.

Keep Reading →

January 13th, 2016 - Market Movers News

Do Hedge Funds Love Glaukos Corp (GKOS)?

The worries about the economic slowdown in China and the ongoing uncertainty about the path of interest-rate increases triggered several waves of equity sell-offs during the third quarter.

Keep Reading →

December 8th, 2015 - Hedge Funds News

Why Are These Four Stocks Hot on The Market on Wednesday?

Four stocks jumped into the green territory by midday on November 11 on the back of an Initial Public Offering, the involvement in legal matters, as well as the disclosure of the financial results for...

Keep Reading →

November 11th, 2015 - Earnings Report Market Movers News

Samuel Isaly's New Healthcare Positions: Community Health Systems (CYH), Glaukos Corp (GKOS), More

Samuel Isaly’s OrbiMed Advisors is a healthcare fund with $15 billion worth of assets under management.

Keep Reading →

August 16th, 2015 - Hedge Fund Analysis Hedge Funds News

Samuel Isaly's OrbiMed Advisors Discloses Large Stake in Glaukos Corp (GKOS) After Its IPO

Glaukos Corp (NYSE:GKOS) is an $870 million developer of products for the treatment of glaucoma, which conducted its IPO last week with 6.90 million shares at $18.00 per unit.

Keep Reading →

July 1st, 2015 - Hedge Funds News